Evidence map›Paper›PMID 19073867›Full record

ArticleJournal of clinical microbiology2009

Multiplex assay for simultaneously typing and subtyping influenza viruses by use of an electronic microarray.

Ying Huang, Huong Tang, Stuart Duffy, Yuwen Hong, Sylvia Norman, Madhu Ghosh, Jie He, Michael Bose, Kelly J Henrickson, Jiang Fan and 3 more

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Diagnostics and surveillance for Swine influenza.Current topics in microbiology and immunology · 2013
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Transcriptomics and proteomics in the study of H1N1 2009.Genomics, proteomics & bioinformatics · 2010
    Review
  12. Methods for molecular surveillance of influenza.Expert review of anti-infective therapy · 2010
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Ying HuangNanogen Inc, San Diego, CA 92121. yhuang@nanogen.com
Huong Tang
Stuart Duffy
Yuwen Hong
Sylvia Norman
Madhu Ghosh
Jie He
Michael Bose
Kelly J Henrickson
Jiang Fan
Andrea J Kraft
William G Weisburg
Elizabeth L Mather
Nanogen (United States) · USMedical College of Wisconsin · US

Funding

Rapid point-of-care diagnostic for bioterrorism "A" agents and Pandemic influenzaU01AI070428 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI HENRICKSON, KELLY J. · 2006 to 2010
$8.5M
Diagnostics for Sepsis and Community-Acquired PneumoniaU01AI066584 · NIAID · NEXOGEN, INC. · PI MATHER, PH.D., ELIZABETH L · 2005 to 2009
$2.4M
NIAID NIH HHS AI066584NIAID NIH HHS AI070428NIAID NIH HHS U01 AI066584NIAID NIH HHS U01 AI070428
6 · The paper itself

Abstract

We report on the use of an electronic microarray to simultaneously type influenza A and B viruses and to distinguish influenza A virus subtypes H1N1 and H3N2 from the potentially pandemic avian virus subtype H5N1. The assay targets seven genes: the H1, H3, H5, N1, and N2 genes of influenza A virus; the matrix protein M1 gene of influenza A virus; and the nonstructural protein (NS) gene of influenza B virus. By combining a two-step reverse transcription-multiplex PCR with typing and subtyping on the electronic microarray, the assay achieved an analytical sensitivity of 10(2) to 10(3) copies of transcripts per reaction for each of the genes. The assay correctly typed and subtyped 15 different influenza virus isolates, including two influenza B virus, five A/H1N1, six A/H3N2, and two A/H5N1 isolates. In addition, the assay correctly identified 8 out of 10 diluted, archived avian influenza virus specimens with complete typing and subtyping information and 2 specimens with partial subtyping information. In a study of 146 human clinical specimens that had previously been shown to be positive for influenza virus or another respiratory virus, the assay showed a clinical sensitivity of 96% and a clinical specificity of 100%. The assay is a rapid, accurate, user-friendly method for simultaneously typing and subtyping influenza viruses.

Indexed as

GenotypeHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza A Virus, H5N1 SubtypeInfluenza B virusMicroarray AnalysisReverse Transcriptase Polymerase Chain ReactionRNA, ViralSensitivity and SpecificityViral ProteinsRNA, ViralViral Proteins

Identifiers

PMID19073867
PMCPMC2643674
OpenAlexW2126059793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.